Free Newsletter
Opportunity knocks for software makers


OK, software makers, you're up.
Drug developers need capacity-planning solutions--really good ones that account for resource costs (see related story). And they have to be up to the challenges of increasingly complex clinical trial protocols, including those for adaptive trials, and accurate enough to show cost savings.
Yes, you've provided clinical capacity-planning features within trial management solutions. But now it's time to step it up a notch, says Kenneth Kaitin of the Tufts Center for the Study of Drug Development.
The need is now for capacity-planning solutions based on an accurate understanding of resource costs. Here's your chance to shine.
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




